SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (2313)7/23/2010 1:56:03 PM
From: tuck1 Recommendation  Respond to of 3027
 
Authorized generic issue has been kicked around more on IHub:

siliconinvestor.com

siliconinvestor.com

follow the reply chains a bit for a pretty complete discussion. How's you're game theory?

Cheers, Tuck



To: fred hayes who wrote (2313)7/23/2010 1:59:27 PM
From: rkrw  Read Replies (1) | Respond to of 3027
 
Since they have no patent they can't get an injunction.

As far as an authorized generic, I don't think it makes sense so long as there's only one generic. I think they'll have a quasi dollar split of the market with Sandoz taking only a modest discount, 20-25%. But we'll see.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News